Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Efficacy of Sodium Bicarbonate vs Heparin as Locking Solutions for Tunneled Hemodialysis Catheters
TCTR20200610003Phase 3Terminated
- Sponsor
- Chulalongkorn University
- Start
- Jun 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of sodium bicarbonate, heparin in end-stage kidney disease (ESKD), sponsored by Chulalongkorn University. Started Jun 2020; status: terminated.
02
Drugs
sodium bicarbonateheparin
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on TCTR20200610003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200610003.